Comparative Effectiveness of Secukinumab and Golimumab in Ankylosing Spondylitis: Assessed By Matching-Adjusted Indirect Comparison Using Pivotal Phase 3 Clinical Trial Data

被引：0
|
作者：
Maksymowych, Walter P. [1 ]
Choy, Ernest [2 ]
Yazici, Yusuf [3 ]
Walsh, Jessica A. [4 ]
Thom, Howard [5 ]
Kalyvas, Chrysostomos [6 ]
Fox, Todd [7 ]
Gandhi, Kunal [8 ]
Jugl, Steffen [7 ]
机构：
[1] Univ Alberta, Radiol & Diagnost Imaging, Edmonton, AB, Canada
[2] Cardiff Univ, Sect Rheumatol, Cardiff, S Glam, Wales
[3] NYU, Sch Med, New York, NY USA
[4] Univ Utah, Div Rheumatol, Salt Lake City, UT USA
[5] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England
[6] MAPI Grp, Real World Strategy & Analyt, Houten, Netherlands
[7] Novartis Pharma AG, Basel, Switzerland
[8] Novartis Pharmaceut, E Hanover, NJ USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1546
引用
收藏
页数：3
相关论文
共 50 条
  • [31] SECUKINUMAB SHOWS HIGHER SYMPTOMATIC IMPROVEMENT VERSUS INFLIXIMAB IN PSORIATIC ARTHRITIS: COMPARATIVE EFFECTIVENESS UP TO 1 YEAR ASSESSED BY MATCHING-ADJUSTED INDIRECT COMPARISONS
    Strand, V
    McInnes, I.
    Thom, H.
    Hunger, M.
    Lopes, N.
    Gandhi, K.
    Jugl, S. M.
    VALUE IN HEALTH, 2017, 20 (09) : A935 - A936
  • [32] Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison (vol 5, pg 99, 2018)
    Nash, Peter
    McInnes, Iain B.
    Mease, Philip J.
    Thom, Howard
    Hunger, Matthias
    Karabis, Andreas
    Gandhi, Kunal
    Mpofu, Shephard
    Jugl, Steffen M.
    RHEUMATOLOGY AND THERAPY, 2018, 5 (02) : 595 - 595
  • [33] A COST PER RESPONDER ANALYSIS OF SECUKINUMAB VS. ADALIMUMAB BASED ON A MATCHING-ADJUSTED INDIRECT COMPARISON OF EFFICACY DATA FOR THE TREATMENT OF ANKYLOSING SPONDYLITIS AT 52 WEEKS FROM THE IRISH PAYER PERSPECTIVE
    Gunda, P.
    Nikoglou, E.
    Jugl, S. M.
    Murphy, A.
    VALUE IN HEALTH, 2017, 20 (09) : A533 - A533
  • [34] SECUKINUMAB PROVIDES HIGHER SYMPTOMATIC IMPROVEMENT VERSUS ADALIMUMAB IN PSORIATIC ARTHRITIS: COMPARATIVE EFFECTIVENESS UP TO 48 WEEKS ASSESSED BY TWO MATCHING-ADJUSTED INDIRECT COMPARISONS
    Thom, H.
    Hunger, M.
    Rosal, G. F.
    Gandhi, K.
    Jugl, S. M.
    Nash, P.
    VALUE IN HEALTH, 2017, 20 (09) : A935 - A935
  • [35] Comparative effectiveness using a matching-adjusted indirect comparison between delayed-release dimethyl fumarate and fingolimod for the treatment of multiple sclerosis
    Fox, Robert J.
    Chan, Andrew
    Zhang, Annie
    Xiao, James
    Levison, Dane
    Lewin, James B.
    Edwards, Michael R.
    Marantz, Jing L.
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (02) : 175 - 183
  • [36] Comparative Clinical Efficacy of Sarilumab versus Upadacitinib over 12 Weeks: Matching-Adjusted Indirect Comparison Analysis
    Huizinga, Thomas
    Choy, Ernest
    Praestgaard, Amy
    van Hoogstraten, Hubert
    LaFontaine, Patrick R.
    Guyot, Patricia
    Aletaha, Daniel
    Mueller-Ladner, Ulf
    Tanaka, Yoshiya
    Curtis, Jeffrey R.
    Fleischmann, Roy
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [37] Comparative effectiveness using a matching-adjusted indirect comparison between delayed-release dimethyl fumarate and glatiramer acetate in multiple sclerosis patients
    Chan, A.
    Cutter, G.
    Fox, R.
    Zhang, A.
    Xiao, J.
    Lewin, J.
    Edwards, M.
    Marantz, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 401 - 401
  • [38] Comparative effectiveness of upadacitinib versus ustekinumab in patients with moderately to severely active Crohn's disease: a matching-adjusted indirect comparison
    Ma, C.
    Dubinsky, M. C.
    Axelrad, J.
    Anyanwu, S.
    Tran, J.
    Lacerda, A.
    Joshi, N.
    Griffith, J.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1866 - I1867
  • [39] Comparative effectiveness of pegcetacoplan versus ravulizumab in patients with paroxysmal nocturnal hemoglobinuria previously treated with eculizumab: a matching-adjusted indirect comparison
    Bhak, Rachel H.
    Mody-Patel, Nikita
    Baver, Scott B.
    Kunzweiler, Colin
    Yee, Christopher W.
    Sundaresan, Sanjana
    Swartz, Natalia
    Duh, Mei Sheng
    Krishnan, Sangeeta
    Sarda, Sujata P.
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (11) : 1913 - 1923
  • [40] Comparative Effectiveness of Pegcetacoplan Versus Ravulizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria Previously Treated with Eculizumab: A Matching-Adjusted Indirect Comparison
    Bhak, Rachel Y.
    Mody-Patel, Nikita
    Baver, Scott B.
    Kunzweiler, Colin
    Yee, Christopher
    Sundaresan, Sanjana
    Swartz, Natalia
    Duh, Mei Sheng
    Krishnan, Sangeeta
    Sarda, Sujata P.
    BLOOD, 2020, 136
12345